Latifat Adelekan-Adeogun
Psychiatric/Mental Health · Mansfield, TXNPI 1689124125
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $20,625 of the $28,510 with a category attached, or 72.3%. AbbVie accounts for 98.5% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2021 at $28,087 and has fallen 98.9% since, to $298 in 2025. Among psychiatric/mental health clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 65 payments — averaging $438.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$28K
- Supernus Pharmaceuticals, Inc.$151
- Johnson & Johnson$148
- Braeburn Inc.$124
What the payments were for
- Speaking & faculty fees$20,62572%
- Travel & lodging$6,91824%
- Food & beverage$9673%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 58 | $28,087 |
| Supernus Pharmaceuticals, Inc. | 3 | $151 |
| Johnson & Johnson | 3 | $148 |
| Braeburn Inc. | 1 | $124 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$28,510 in reported general payments places this provider in the 95th percentile of 2,724 psychiatric/mental health providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Paliperidone ErPaliperidone | 25 | $6,220 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 26 | $1,644 |
| Aripiprazole | 60 | $1,347 |
| Hydroxyzine Hcl | 65 | $1,285 |
| Ziprasidone Hcl | 20 | $1,079 |
| Oxcarbazepine | 14 | $936 |
| Olanzapine | 40 | $848 |
| Bupropion XlBupropion Hcl | 56 | $786 |
| Buspirone Hcl | 82 | $775 |
| Benztropine Mesylate | 77 | $726 |
| Duloxetine Hcl | 52 | $688 |
| Trazodone Hcl | 108 | $478 |
| Quetiapine Fumarate | 39 | $461 |
| Divalproex Sodium | 14 | $457 |
| Risperidone | 41 | $342 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Mansfield
- Tracy HicksLongview$684K
- Natalie TellezHouston$602K
- Karah BrashierRichardson$567K
- Grant DavisRichardson$360K
- Victor IlogEl Paso$167K
- Lisa ShamblinGrapevine$163K
- Monique GonzalezSan Antonio$126K
- Marguerite AddisonWaco$118K
- Komi Kokou-AbiRound Rock$88K
- Jaime Nelson DensonAustin$88K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.